MMIRF
Price
$0.05
Change
+$0.04 (+400.00%)
Updated
Jul 22 closing price
Capitalization
38.69M
TECX
Price
$22.32
Change
+$0.04 (+0.18%)
Updated
Jul 25 closing price
Capitalization
416.77M
Interact to see
Advertisement

MMIRF vs TECX

Header iconMMIRF vs TECX Comparison
Open Charts MMIRF vs TECXBanner chart's image
Medmira
Price$0.05
Change+$0.04 (+400.00%)
Volume$1.5K
Capitalization38.69M
Tectonic Therapeutic
Price$22.32
Change+$0.04 (+0.18%)
Volume$155.42K
Capitalization416.77M
MMIRF vs TECX Comparison Chart in %
Loading...
MMIRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MMIRF vs. TECX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MMIRF is a Buy and TECX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (MMIRF: $0.05 vs. TECX: $22.32)
Brand notoriety: MMIRF and TECX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MMIRF: 18% vs. TECX: 78%
Market capitalization -- MMIRF: $38.69M vs. TECX: $416.77M
MMIRF [@Biotechnology] is valued at $38.69M. TECX’s [@Biotechnology] market capitalization is $416.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MMIRF’s FA Score shows that 1 FA rating(s) are green whileTECX’s FA Score has 1 green FA rating(s).

  • MMIRF’s FA Score: 1 green, 4 red.
  • TECX’s FA Score: 1 green, 4 red.
According to our system of comparison, MMIRF is a better buy in the long-term than TECX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MMIRF’s TA Score shows that 3 TA indicator(s) are bullish while TECX’s TA Score has 5 bullish TA indicator(s).

  • MMIRF’s TA Score: 3 bullish, 4 bearish.
  • TECX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TECX is a better buy in the short-term than MMIRF.

Price Growth

MMIRF (@Biotechnology) experienced а +257.86% price change this week, while TECX (@Biotechnology) price change was +1.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

MMIRF is expected to report earnings on Jul 01, 2025.

TECX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECX($417M) has a higher market cap than MMIRF($38.7M). MMIRF YTD gains are higher at: 282.443 vs. TECX (-51.657). MMIRF has higher annual earnings (EBITDA): -3.24M vs. TECX (-56.94M). TECX has more cash in the bank: 306M vs. MMIRF (18.3K). TECX has less debt than MMIRF: TECX (2.63M) vs MMIRF (10.2M). MMIRF has higher revenues than TECX: MMIRF (254K) vs TECX (0).
MMIRFTECXMMIRF / TECX
Capitalization38.7M417M9%
EBITDA-3.24M-56.94M6%
Gain YTD282.443-51.657-547%
P/E RatioN/AN/A-
Revenue254K0-
Total Cash18.3K306M0%
Total Debt10.2M2.63M388%
FUNDAMENTALS RATINGS
MMIRF vs TECX: Fundamental Ratings
MMIRF
TECX
OUTLOOK RATING
1..100
465
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
21
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10093
PRICE GROWTH RATING
1..100
3658
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MMIRF's Valuation (5) in the null industry is in the same range as TECX (21). This means that MMIRF’s stock grew similarly to TECX’s over the last 12 months.

MMIRF's Profit vs Risk Rating (100) in the null industry is in the same range as TECX (100). This means that MMIRF’s stock grew similarly to TECX’s over the last 12 months.

TECX's SMR Rating (93) in the null industry is in the same range as MMIRF (100). This means that TECX’s stock grew similarly to MMIRF’s over the last 12 months.

MMIRF's Price Growth Rating (36) in the null industry is in the same range as TECX (58). This means that MMIRF’s stock grew similarly to TECX’s over the last 12 months.

MMIRF's P/E Growth Rating (100) in the null industry is in the same range as TECX (100). This means that MMIRF’s stock grew similarly to TECX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MMIRFTECX
RSI
ODDS (%)
Bearish Trend 1 day ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
52%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 19 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MMIRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TOSCF15.11N/A
N/A
Tosoh Corp.
CATWF0.07N/A
N/A
China Tontine Wines Group Ltd.
NZERF0.16N/A
N/A
New Zealand Energy Corp.
PLRRF6.40N/A
N/A
Polar Capital Holdings PLC
DLICY15.94-0.13
-0.81%
Dai-ichi Life Holdings Inc

MMIRF and

Correlation & Price change

A.I.dvisor tells us that MMIRF and NWPHF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MMIRF and NWPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MMIRF
1D Price
Change %
MMIRF100%
N/A
NWPHF - MMIRF
30%
Poorly correlated
N/A
TECX - MMIRF
29%
Poorly correlated
+0.18%
AZTR - MMIRF
24%
Poorly correlated
-4.34%
SRPT - MMIRF
22%
Poorly correlated
-7.38%
SAGE - MMIRF
22%
Poorly correlated
+0.46%
More

TECX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECX has been loosely correlated with IGC. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TECX jumps, then IGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECX
1D Price
Change %
TECX100%
+0.18%
IGC - TECX
49%
Loosely correlated
-0.65%
LPTX - TECX
38%
Loosely correlated
-1.56%
IMNM - TECX
36%
Loosely correlated
-3.29%
ATHE - TECX
35%
Loosely correlated
+15.32%
SRPT - TECX
35%
Loosely correlated
-7.38%
More